Pelareorep,Paclitaxel,Avelumab
Oncolytics Biotech,Merck,Pfizer
['bcsm', 'breast', 'mbc']
oncolytics kol webinar on data from the randomized phase 2 bracelet-1 trial in hr+ / her2- metastatic breast cancer being presented at the upcoming #asco23 annual meeting. #mbc #metastaticbreastcancer #clinicaltrials #cancerresearch #denovombc #bcsm 